The research at Neuronal Survival Unit, Lund University, Sweden is focused on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s and Alzheimer’s diseases. We also study cell replacement therapy with stem cells in attempts to repair brains in animal models of Parkinson’s diseases. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers.
The 23rd Neuropharmacology Conference 2013 takes place in San Diego, US, November 7-8, 2013. Patrik Brundin is invited to give a talk, and Nolwen Rey and Nicole Reichenbach will present posters.
See the program at:
Two Nesu members have received funding from The Parkinson Foundation in Sweden.
Christopher Dunning received a grant of 150.000 SEK for the project "Exosomes, alpha-Synuclein aggregation and cell-to-cell transfer" and Ulrika Nordström received a grant of 269.630 SEK for the project "Exenatide as disease modifying therapy in Parkinson´s disease".